These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27911301)

  • 1. Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.
    Slachevsky A; Guzmán-Martínez L; Delgado C; Reyes P; Farías GA; Muñoz-Neira C; Bravo E; Farías M; Flores P; Garrido C; Becker JT; López OL; Maccioni RB
    J Alzheimers Dis; 2017; 55(4):1595-1603. PubMed ID: 27911301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population.
    Guzmán-Martínez L; Tapia JP; Farías GA; González A; Estrella M; Maccioni RB
    J Alzheimers Dis; 2019; 67(4):1181-1186. PubMed ID: 30775977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.
    Deters KD; Risacher SL; Kim S; Nho K; West JD; Blennow K; Zetterberg H; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
    J Alzheimers Dis; 2017; 58(4):1245-1254. PubMed ID: 28550246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelets tau: a potential peripheral marker for Alzheimer's disease.
    Neumann K; Farías G; Slachevsky A; Perez P; Maccioni RB
    J Alzheimers Dis; 2011; 25(1):103-9. PubMed ID: 21368381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.
    Ossenkoppele R; Mattsson N; Teunissen CE; Barkhof F; Pijnenburg Y; Scheltens P; van der Flier WM; Rabinovici GD
    Neurobiol Aging; 2015 Aug; 36(8):2340-7. PubMed ID: 25990306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early Alzheimer's disease.
    Chiu MJ; Chen YF; Chen TF; Yang SY; Yang FP; Tseng TW; Chieh JJ; Chen JC; Tzen KY; Hua MS; Horng HE
    Hum Brain Mapp; 2014 Jul; 35(7):3132-42. PubMed ID: 24129926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    Reiter K; Nielson KA; Durgerian S; Woodard JL; Smith JC; Seidenberg M; Kelly DA; Rao SM
    J Alzheimers Dis; 2017; 55(4):1363-1377. PubMed ID: 27834774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.
    Mullins RJ; Mustapic M; Goetzl EJ; Kapogiannis D
    Hum Brain Mapp; 2017 Apr; 38(4):1933-1940. PubMed ID: 28105773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
    Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet Tau Protein as a Potential Peripheral Biomarker in Alzheimer's Disease: An Explorative Study.
    Mukaetova-Ladinska EB; Abdell-All Z; Andrade J; da Silva JA; Boksha I; Burbaeva G; Kalaria RN; T O Brien J
    Curr Alzheimer Res; 2018; 15(9):800-808. PubMed ID: 29623842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.
    Solé-Padullés C; Lladó A; Bartrés-Faz D; Fortea J; Sánchez-Valle R; Bosch B; Antonell A; Molinuevo JL; Rami L
    Psychiatry Res; 2011 Jun; 192(3):140-6. PubMed ID: 21546220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.
    Sintini I; Martin PR; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Spychalla AJ; Drubach DA; Knopman DS; Petersen RC; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Neuroimage Clin; 2019; 23():101823. PubMed ID: 31004914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet tau pattern correlates with cognitive status in Alzheimer's disease.
    Farías G; Pérez P; Slachevsky A; Maccioni RB
    J Alzheimers Dis; 2012; 31(1):65-9. PubMed ID: 22495344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau PET Distributional Pattern in AD Patients with Visuospatial Dysfunction.
    Sun X; Nie B; Zhao S; Chen Q; Li P; Zhang T; Pan T; Feng T; Wang L; Yin X; Zhang W; Zhao S; Shan B; Liu H; Liang S; Ai L; Wang G
    Curr Alzheimer Res; 2019; 16(11):1055-1062. PubMed ID: 31724513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
    Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM
    JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study.
    Di Paola M; Macaluso E; Carlesimo GA; Tomaiuolo F; Worsley KJ; Fadda L; Caltagirone C
    J Neurol; 2007 Jun; 254(6):774-81. PubMed ID: 17404777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.